Vella A. Silcox - Concepedia

Author

Vella A. Silcox

Centers for Disease Control and Prevention

Also Known As

V A Silcox, V Silcox, V. A. SILCOX, V. A. Silcox, V. Silcox, Vella A Silcox, Vella A. Silcox, Vella Silcox

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention The University of Texas Health Science Center at Tyler Chubu National Hospital Queensland Health National Center for Infectious Diseases

About

Vella A. Silcox is an author at Centers for Disease Control and Prevention specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	2.5K
2	Health Sciences	7	7	507
3	Engineering	5	5	277
4	Natural Sciences	2	2	111
5	Biochemistry	2	2	71

Vella A. Silcox

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
<i>Mycobacterium chelonae</i>Wound Infections after Plastic Surgery Employing Contaminated Gentian Violet Skin-Marking Solution Thomas J. Safranek, William R. Jarvis, Loretta A. Carson, New England Journal of Medicine Medical MicrobiologySurgical Site InfectionsMicrobial DiseaseAntibioticsSurgical Procedures	1987	272
Treatment of Nonpulmonary Infections Due to Mycobacterium fortuitum and Mycobacterium chelonei on the Basis of in Vitro Susceptibilities Richard J. Wallace, Jana M. Swenson, Vella A. Silcox, The Journal of Infectious Diseases Antibiotic AdjuvantSurgeryAntimicrobial ChemotherapyDrug ResistanceInfection Control	1985	269
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae Jana M. Swenson, R. J. WALLACE, Vella A. Silcox, Antimicrobial Agents and Chemotherapy Medical MicrobiologyMycobacterium ChelonaeAntimicrobial SusceptibilitySpecies SubgroupsAntibiotics	1985	256
Infections with Mycobacterium chelonei in Patients Receiving Dialysis and Using Processed Hemodialyzers Gail Bolan, Arthur Reingold, L. A. Carson, The Journal of Infectious Diseases	1985	222
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution Jana M. Swenson, Clyde Thornsberry, Vella A. Silcox Antimicrobial Agents and Chemotherapy Medical MicrobiologyAntimicrobial SusceptibilityAntibioticsSusceptibility TestingAgar Dilution	1982	186
Identification of clinically significant Mycobacterium fortuitum complex isolates Vella A. Silcox, Robert C. Good, Margaret M. Floyd Journal of Clinical Microbiology Pathogenic MicrobiologyEngineeringAntimicrobial SusceptibilityMicrobial DiseasePathology	1981	172
Peritonitis Due to a Mycobacterium chelonei-Like Organism Associated with Intermittent Chronic Peritoneal Dialysis J Band, Joel I. Ward, David W. Fraser, The Journal of Infectious Diseases Undergone CpdMedical MicrobiologyMicrobial ContaminationCpd MachinesPeritonitis Due	1982	165
Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis Bonnie B. Plikaytis, Brian D. Plikaytis, Mitchell A. Yakrus, Journal of Clinical Microbiology Gene AmplificationGene Amplification StepGeneticsTuberculosis PreventionBacteriology	1992	162
Human Disease Due to Mycobacterium smegmatis Richard J. Wallace, Donald R. Nash, M Tsukamura, The Journal of Infectious Diseases Mycobacterium SmegmatisM. SmegmatisMedical MicrobiologyPathogenic MicrobiologyAntimicrobial Susceptibility	1988	160
A Co-operative Numerical Analysis of Rapidly Growing Mycobacteria George P. Kubica, I. Baess, Ruth Gordon, Journal of General Microbiology	1972	141

Page 1